$10.01 -0.06 (-0.60%)
11/20/2009 4:00 PM

Protalix BioTherapeutics, Inc. (PLX)

CAPS Rating: 1 out of 5

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

Current Price $10.01 Mkt Cap $773.43M
Open $10.07 P/E Ratio 0.00
Prev. Close $10.07 Div. (Yield) N/A (N/A)
Daily Range $9.71 - $10.09 Volume 680,852
52-Wk Range $0.96 - $12.50 Avg. Daily Vol. 941,000

PLX News and Commentary

Related News and Articles

Caps

How do you think PLX will perform vs the S&P 500?

Add Stock to Watchlist

All Members

84 Outperform
78 Underperform
 

All-Star Members

26 Outperform
41 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top PLX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

yellowear (70.35)
Submitted December 20, 2008

Based on the news on the street and the performance of the stock at these levels, this company has the potential of reaching 2000% in the next 4 years. This stock has found a bottom like AKS did several years ago which reached a high of 70+ before it… More

0 Comments | Reply | Report this Post

TMFBiologyFool (93.17)
Submitted July 06, 2009

The FDA asking for free drug doesn't make the stock more valuable.

0 Comments | Reply | Report this Post
PLX VS S&P 500 (SPY)

Fools bullish on PLX are also bullish on:

Fools bearish on PLX are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about PLX.

Recs

0
Member Avatar pjani06 (98.23) Submitted: 11/4/2009 10:22:50 PM : Underperform Start Price: $12.00 PLX Score: +17.95

stock that has shot up alot in past year yet are in CAPs.

Report this Post 1 Comment | Reply | Permalink

Recs

0
Member Avatar movadoman51 (< 20) Submitted: 11/4/2009 12:37:36 AM : Outperform Start Price: $10.93 PLX Score: -12.13

New technology!!! will bit all pharma co.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar devilzadvocate (96.69) Submitted: 11/2/2009 8:08:30 AM : Outperform Start Price: $9.90 PLX Score: -3.98

This is based on M&A activity -
"Pfizer eyes cooperation with Protalix, if it doesn't snap it up first"

Report this Post 0 Comments | Reply | Permalink
View All 32 Pitches »

Leaderboard

Find the members with the highest scoring picks in PLX.

Score Leader

mpowtcdioyauten

mpowtcdioyauten (60.43) Score: +530.32

The Score Leader is the member with the highest score across all their picks in PLX.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
mpowtcdioyauten 60.43 12/15/2008 Outperform NS $1.52 +558.55% +28.24% +530.32
acodalbu 82.42 12/8/2008 Outperform 5Y $1.62 +517.90% +24.27% +493.63 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. yellowear 70.35 12/8/2008 12/21/2008 Outperform 5Y $1.62 +517.90% +24.27% +493.63 1 Comment
Render311 < 20 10/10/2008 Outperform NS $1.76 +470.05% +24.08% +445.96
october92008 98.42 10/9/2008 Outperform NS $1.87 +435.29% +12.70% +422.59
1st2 < 20 1/8/2009 Outperform NS $1.91 +424.08% +23.20% +400.88
osusports10 < 20 8/14/2008 Outperform 5Y $2.64 +279.17% -11.70% +290.87
bg11235 93.13 4/6/2009 Outperform NS $2.37 +322.36% +34.12% +288.24
BocaYid < 20 8/4/2008 Outperform 5Y $2.65 +277.74% -10.41% +288.15
SubaJew 93.97 8/4/2008 Outperform 5Y $2.65 +277.74% -10.41% +288.15
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackCanaccord 78.23 9/23/2009 Outperform NS $7.55 +32.58% +2.19% +30.39
TrackHapoalim 45.06 9/2/2009 Outperform NS $6.85 +46.13% +10.19% +35.94
TrackUBS 88.39 3/11/2008 Outperform NS $2.82 +254.96% -12.76% +267.72

Featured Broker Partners